Professional
Added to YB: 2025-08-08
Pitch date: 2025-06-30
EW [bullish]
Edwards Lifesciences Corporation
+6.92%
current return
Author Info
No bio for this author
Company Info
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally.
Market Cap
$50.0B
Pitch Price
$77.70
Price Target
N/A
Dividend
N/A
EV/EBITDA
25.79
P/E
37.70
EV/Sales
7.97
Sector
Health Care Equipment and Supplies
Category
growth
Baron Health Care Fund New Position: Edwards Lifesciences Corporation
EW (new position): Leading heart valve company with dominant TAVR position ($5B market) growing as indications expand and Boston Scientific exits. Evoque tricuspid valve replacement launching into high unmet need market potentially larger than TAVR. Expect high-single to low-double digit revenue growth and mid-teens EPS growth long-term.
Read full article (1 min)